Acetylshengmanol Arabinoside NEW
Price | $39 | $86 | $123 |
Package | 1mg | 5mg | 10mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-07 |
Product Details
Product Name: Acetylshengmanol Arabinoside | CAS No.: 402513-88-6 |
Purity: 99.62% | Supply Ability: 10g |
Release date: 2024/11/07 |
Product Introduction
Bioactivity
名稱 | Acetylshengmanol Arabinoside |
描述 | Acetylcimigenol 3-O-alpha-L-arabinopyranoside is an extract derived from Cimicifuga. |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 9 mg/mL (13.58 mM) |
關(guān)鍵字 | inhibit | Acetylcimigenol 3-O-a-L-arabinopyran | Inhibitor | Acetylshengmanol Arabinoside | Acetylcimigenol 3-O-α-L-arabinopyran |
相關(guān)庫 | 萜類天然產(chǎn)物庫 | 中藥單體化合物庫 | 植物來源化合物庫 | 天然產(chǎn)物庫 | 糖類及苷類化合物庫 | 高通量篩選天然產(chǎn)物庫 | 天然產(chǎn)物共價(jià)化合物庫 | 共價(jià)抑制劑庫 | 抗COVID-19化合物庫 | 古代經(jīng)典名方目錄分子庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/25Kg |
VIP1Y
|
Xinxiang Aurora Biotechnology Co.,Ltd.
|
2024-10-28 | |
$0.00/25kg |
Shaanxi Haibo Biotechnology Co., Ltd
|
2023-08-30 | ||
$0.00/5mg |
Shanghai Standard Technology Co., Ltd.
|
2020-04-27 |
- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY